DIMET

Department of Translational Medicine

- From pathobioLogy to synoviA on chip: driving rheuMatoId arthritis to the precisioN medicine GOal

Rheumatoid arthritis (RA) is an autoimmune disorder, characterised by inflammation of the synovial (joint-lining) membrane, which affects 1% of the population. If not treated, it can lead to joint deformity and permanent disability. There is not yet a cure for RA but prompt treatment with anti-rheumatic drugs (DMARD) can slow down its development, protecting joints from permanent damage.

- New generation cell therapy to cure type 1 Diabetes

The VANGUARD project aims to generate a bioartificial vascularized and immunoprotected pancreas that can be transplanted into non-immunosuppressed patients, combining advanced elements of tissue engineering such as 3D organoids, hydrogel design, the assembly of bioartificial organs and gene editing via CRISPR-Cas9.

This approach will produce cell therapy in the form of an advanced therapy medicinal product (ATMP), which can significantly improve the treatment of type 1 diabetes.

The project involves a consortium with 9 partners from 5 European countries.

- An integrated APProach focusEd on defining the moleculAr and biological mechanisms reguLatING viral reactivation and persistence

Persistent or latent viral infections constitute a significant problem, particularly in individuals with reduced immune systems which can easily submit to reactivation of the virus with harmful consequences for the host.

The mechanisms that result in reactivation of these viruses are still little-known, making them a sizeable challenge for scientific researchers.

The goal of this project (funded by PRIN 2017) is to increase our knowledge of virus-host interaction, in order to identify: